Healthsonix Inc. DL-,001
21.01.08 18:33
#826
schupo
h
Oberbayrischer Börsenbrief schrieb am 20.09.2006 Strong by kursziel 5 Euro.Da kann ich nur zu sagen"Au Backe" das muss doch derbe Wehtun.
30.01.08 14:52
#834
buran
so Leute,hier mal ein wenig auf's Tempo achten!
Letzter Vortag Umsatz Veränderung
0,097 € 0,070 € 2.322 € +38,57%
Börsenplatz: Frankfurt Stand: 14:31
0,097 € 0,070 € 2.322 € +38,57%
Börsenplatz: Frankfurt Stand: 14:31
19.02.08 12:23
#835
buran
ich verkaufe nicht
jedenfalls jetzt noch nicht.Hier sauge ich mindestens 50% raus,DU LUDER!
21.02.08 12:02
#837
buran
man muss sich ja nicht immer rechtfertigen
aber die Beteiligung der anderen Anleger lässt doch sehr zu wünschen übrig.
Also ich sage es mal an dieser Stelle.Ich bin hier invstiert und fühle mich irgendwie im Stich gelassenWobei Stich gut ist,den brauch man unter der Mütze auch ,um solch einen Wert zu ordern.Mit-61% im Depot steht man natürlich nicht gerade rosig da.Ich stehe aber dazu und eines Tages wird Healthonix wieder zum Leben erwecken und dann kommen sie wieder alle daher und rühmen sich mit ihrer tatkräftigen Unterstützung.Ich bleibe auf jedenfall am Ball und schaue allwöchentlich hier rein.
Gruß buran
Also ich sage es mal an dieser Stelle.Ich bin hier invstiert und fühle mich irgendwie im Stich gelassenWobei Stich gut ist,den brauch man unter der Mütze auch ,um solch einen Wert zu ordern.Mit-61% im Depot steht man natürlich nicht gerade rosig da.Ich stehe aber dazu und eines Tages wird Healthonix wieder zum Leben erwecken und dann kommen sie wieder alle daher und rühmen sich mit ihrer tatkräftigen Unterstützung.Ich bleibe auf jedenfall am Ball und schaue allwöchentlich hier rein.
Gruß buran
07.03.08 11:06
#839
buran
richtig
kaum mehr Handel.Ein Fall für die Börsenaufsicht,denn ich sehe nicht ein dass ich hier nur noch allein gelassen werde.Ich will mein Geld zurück!
07.03.08 11:26
#840
buran
Falls sich doch noch einer hierher verirrt,bitte:
http://www.boersenaufsicht.de/
10.03.08 14:16
#843
Limitless
hallo buran
deine treue in ehren!!!
aber bei börse und aktien iss sie doch m.E. völlig fehl am platz.
Wünsche dir, das du aus deinen miesen hier wieder rauskommst... lg. limi
aber bei börse und aktien iss sie doch m.E. völlig fehl am platz.
Wünsche dir, das du aus deinen miesen hier wieder rauskommst... lg. limi
13.03.08 09:44
#845
buran
frisch von gestern:
HealthSonix to Conduct Clinical Trials with ZingiberRx for Complex Regional Pain Syndrome (CRPS)
14:50 12.03.08
IRVINE, Calif.--(BUSINESS WIRE)--
HealthSonix, Inc. (OTC:HSXI)(FWB:H7S) today announced that it has strong evidence that ZingiberRx Joint and Muscle Cream with ginger oil can provide pain relief for people with Complex Regional Pain Syndrome (CRPS), also referred to as Reflex Sympathetic Dystrophy (RSD).
The main symptom of CRPS is intense chronic pain, often described as burning pain. Additional signs and symptoms include localized swelling; changes in skin temperature and color; joint stiffness; muscle spasms, weakness and loss (atrophy); and decreased range of motion.
We have been testing ZingiberRx with a CRPS group and the on-going positive feedback we get from the participants has led to the decision to conduct a formal scientific study for this condition, said Dieter D. Doederlein, Vice President Corporate Development for HealthSonix.
Members of our St Catharines CRPS support group had excellent outcomes from the ZingiberRx samples you provided. You definitely should consider a clinical trial, said Helen Small, President of PARC, a national support group that is Promoting Awareness of RSD and CRPS in Canada.
According to the Mayo Clinic, many cases of complex regional pain syndrome occur after a forceful trauma to an arm or a leg, as a result of motor vehicle accidents, shrapnel blasts and other traumas - such as surgery, heart attacks, infections, fractures and sprained ankles. This could open up a whole new market for ZingiberRx, added Doederlein.
HealthSonix, Inc. (OTC: HSXI)(FWB: H7S) is a publicly traded research oriented medical technology company that develops and markets medical devices and healthcare products for institutional and consumer use. The companys patent pending medical devices deliver sound pressure waves to the human body for relief of pain and other musculoskeletal conditions. The focus is on arthritis, athletic injuries and conditions where acute or chronic pain is the cardinal symptom.
More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
(c)2007 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
14:50 12.03.08
IRVINE, Calif.--(BUSINESS WIRE)--
HealthSonix, Inc. (OTC:HSXI)(FWB:H7S) today announced that it has strong evidence that ZingiberRx Joint and Muscle Cream with ginger oil can provide pain relief for people with Complex Regional Pain Syndrome (CRPS), also referred to as Reflex Sympathetic Dystrophy (RSD).
The main symptom of CRPS is intense chronic pain, often described as burning pain. Additional signs and symptoms include localized swelling; changes in skin temperature and color; joint stiffness; muscle spasms, weakness and loss (atrophy); and decreased range of motion.
We have been testing ZingiberRx with a CRPS group and the on-going positive feedback we get from the participants has led to the decision to conduct a formal scientific study for this condition, said Dieter D. Doederlein, Vice President Corporate Development for HealthSonix.
Members of our St Catharines CRPS support group had excellent outcomes from the ZingiberRx samples you provided. You definitely should consider a clinical trial, said Helen Small, President of PARC, a national support group that is Promoting Awareness of RSD and CRPS in Canada.
According to the Mayo Clinic, many cases of complex regional pain syndrome occur after a forceful trauma to an arm or a leg, as a result of motor vehicle accidents, shrapnel blasts and other traumas - such as surgery, heart attacks, infections, fractures and sprained ankles. This could open up a whole new market for ZingiberRx, added Doederlein.
HealthSonix, Inc. (OTC: HSXI)(FWB: H7S) is a publicly traded research oriented medical technology company that develops and markets medical devices and healthcare products for institutional and consumer use. The companys patent pending medical devices deliver sound pressure waves to the human body for relief of pain and other musculoskeletal conditions. The focus is on arthritis, athletic injuries and conditions where acute or chronic pain is the cardinal symptom.
More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
(c)2007 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
13.03.08 09:45
#846
buran
Und?
Was sagt uns das?
Nichts.
Das ist ein deutsches Börsenforum.Immer dieser Englischkrempel!Fürchterlich!
Nichts.
Das ist ein deutsches Börsenforum.Immer dieser Englischkrempel!Fürchterlich!
13.03.08 16:13
#848
ptm61
schlechte Neuigkeiten
HSXI ist auch dabei:
http://www.sec.gov/news/press/2008/2008-41.htm
http://www.sec.gov/news/press/2008/2008-41.htm
13.03.08 16:31
#849
schupo
h
das isja super jetzt hab ich jede menge Klopapier an bord.Was fuer ein Mist
13.03.08 17:45
#850
Limitless
a weia! # 848
da sind aber einige namen dabei, die mir von so tollen börsenbriefschreibern wärmstens empfohlen werden... limi